CIK 0001559053
- Accelerated filer
PROTHENA CORP PUBLIC LTD CO
Sign in to watch- Ticker
- PRTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- Operating
- Phone
- +353 12362500
- Business address
- 77 SIR JOHN ROGERSON'S QUAY, BLOCK C, GRAND CANAL DOCKLANDS, DUBLIN 2, Ireland, D02 VK60
- Former names
- Prothena Corp plc, Neotope Corp Ltd
- Open-market buys, last 90 days
- $9,848,721
- in 10 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,848,721. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-07-21 | Nguyen Tran Chief Strategy Officer and CFO | Option exercise | +20,560 | $6.73 | $138K | 23,760 |
| 2022-07-21 | Nguyen Tran Chief Strategy Officer and CFO | Sale | −20,555 | $32.64 | $671K | 3,205 |
| 2022-07-21 | Nguyen Tran Chief Strategy Officer and CFO | Sale | −5 | $33.69 | $168 | 3,200 |
| 2022-07-21 | Nguyen Tran Chief Strategy Officer and CFO | Option exercise · Stock Option (Right to Buy) | −20,560 | 87,320 | ||
| 2022-07-20 | Nguyen Tran Chief Strategy Officer and CFO | Option exercise | +42,120 | $6.73 | $283K | 45,320 |
| 2022-07-20 | Nguyen Tran Chief Strategy Officer and CFO | Sale | −25,136 | $32.32 | $813K | 20,184 |
| 2022-07-20 | Nguyen Tran Chief Strategy Officer and CFO | Sale | −16,984 | $32.73 | $556K | 3,200 |
| 2022-07-20 | Nguyen Tran Chief Strategy Officer and CFO | Option exercise · Stock Option (Right to Buy) | −42,120 | 107,880 | ||
| 2022-07-20 | Cooke Shane Director | Option exercise | +15,000 | $6.41 | $96K | 15,000 |
| 2022-07-20 | Cooke Shane Director | Sale | −15,000 | $32.90 | $494K | 0 |
| 2022-07-20 | Cooke Shane Director | Option exercise · Stock Option (Right to Buy) | −15,000 | 30,000 | ||
| 2022-07-06 | Garren Hideki Chief Medical Officer | Option exercise | +8,000 | $24.90 | $199K | 8,000 |
| 2022-07-06 | Garren Hideki Chief Medical Officer | Sale | −8,000 | $30.00 | $240K | 0 |
| 2022-07-06 | Garren Hideki Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −8,000 | 242,000 | ||
| 2022-05-18 | Patel Sanjiv Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2022-05-18 | Cobb Paula K Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2022-05-18 | Cooke Shane Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2022-05-18 | COLLIER RICHARD T Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2022-05-18 | Harfstrand Karl Anders Olof Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2022-05-18 | Selkoe Dennis J. Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 |
Page 27 of 28 · 555 trades